cytarabine has been researched along with dipyridamole in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Capizzi, RL; White, JC; Yang, JL | 2 |
| Mitsumoto, Y; Mohri, T; Ohkubo, T | 1 |
| Harstrick, A; Köhne-Wömpner, CH; Poliwoda, H; Schmoll, HJ; Schöber, C; Wilke, H | 1 |
| Akiyama, Y; Kiriyama, Y; Kitoh, T; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A | 1 |
| Chan, TC | 1 |
| Howell, SB; King, ME; Naporn, A; Young, B | 1 |
| Horber, DH; Schott, H; Schwendener, RA | 1 |
| Goz, B; Jeffs, L | 1 |
| Connolly, GP; Duley, JA | 1 |
| Cheng, KY; Geller, HM; Goldsmith, NK; Grandison, L; Morris, EJ; Romero, AA; Zhang, AL | 1 |
| Cole, PD; Kamen, BA; Smith, AK | 1 |
| Altundag, K; Babaoglu, MO; Bozkurt, A; Elkiran, T; Karadag, O; Saikawa, Y; Yasar, U | 1 |
| Hiura, T; Ishikawa, M; Kanno, S; Koiwai, K; Ohtake, T; Suzuki, H; Ujibe, M | 1 |
| Adema, AD; Honeywell, RJ; Losekoot, N; Myhren, F; Peters, GJ; Sandvold, ML; Smid, K; Verheul, HM | 1 |
| Baker, SD; Blum, W; Drenberg, CD; Du, G; Gibson, AA; Gruber, TA; Hu, S; Li, L; Nies, AT; Pabla, N; Pounds, SB; Rhinehart, DP; Schwab, M; Shi, L; Sparreboom, A | 1 |
2 review(s) available for cytarabine and dipyridamole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Modulation of cytotoxic drug activity by dipyridamole.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Cytarabine; Dipyridamole; Drug Interactions; Etoposide; Fluorouracil; Humans; Leucovorin; Methotrexate | 1990 |
18 other study(ies) available for cytarabine and dipyridamole
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.
Topics: Biological Transport; Cytarabine; Dipyridamole; Drug Interactions; Humans; Leukemia, Myeloid, Acute; Models, Biological; Tumor Cells, Cultured | 1992 |
Characterization of the uptake of adenosine by cultured rat hippocampal cells and inhibition of the uptake by xanthine derivatives.
Topics: 2-Chloroadenosine; Adenosine; Affinity Labels; Animals; Biological Transport; Caffeine; Cells, Cultured; Cytarabine; Dipyridamole; Embryo, Mammalian; Hippocampus; Kinetics; Neuroglia; Neurons; Pentoxifylline; Rats; Sodium; Theophylline; Thioinosine; Tritium; Xanthines | 1991 |
Enhanced retention of cytosine arabinoside and its metabolites and synergistic cytotoxicity by sequential treatment with dipyridamole in L5178Y leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dipyridamole; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Leukemia, Experimental; Mice; Time Factors; Tritium | 1990 |
Characterization of nucleoside transport during leukemic cell differentiation.
Topics: Biological Transport; Cell Differentiation; Cytarabine; Deoxycytidine Kinase; Dipyridamole; Humans; Inosine; Leukemia, Promyelocytic, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thioinosine; Tretinoin; Tumor Cells, Cultured | 1989 |
Augmentation of 1-beta-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibiting drug efflux.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cytarabine; Dipyridamole; DNA Damage; Drug Synergism; Humans; Tumor Cells, Cultured | 1989 |
Modulation of cytarabine uptake and toxicity by dipyridamole.
Topics: Animals; Biological Transport; Body Weight; Cell Line; Cytarabine; Dipyridamole; Drug Evaluation, Preclinical; Drug Interactions; Humans; Kinetics; Leukemia L1210; Mice | 1984 |
Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cell Differentiation; Cytarabine; Dipyridamole; DNA; Drug Carriers; Drug Interactions; Half-Life; Humans; Leukemia; Liposomes; Tumor Cells, Cultured | 1995 |
The enhancement of the frequency of resistance to N-phosphonoacetyl-L-aspartate and methotrexate by 1-beta-D-arabinofuranosylcytosine: the effect of dipyridamole.
Topics: Animals; Aspartic Acid; Cell Line, Transformed; Cricetinae; Cytarabine; Dipyridamole; Drug Resistance; Drug Synergism; Humans; Methotrexate; Nucleosides; Phosphonoacetic Acid; Thioinosine | 1994 |
Ecto-nucleotidase of cultured rat superior cervical ganglia: dipyridamole is a novel inhibitor.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cells, Cultured; Cytarabine; Dimethylphenylpiperazinium Iodide; Dipyridamole; Extracellular Space; Models, Biological; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Superior Cervical Ganglion; Time Factors; Uridine Triphosphate | 2000 |
Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside.
Topics: Acetylcysteine; Animals; Apoptosis; Biological Transport; Cell Survival; Cells, Cultured; Cerebral Cortex; Cytarabine; Dipyridamole; DNA Damage; Embryo, Mammalian; Free Radical Scavengers; Kinetics; Models, Neurological; Neurons; Oxidative Stress; Rats; Uric Acid; Vitamin E | 2001 |
Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Bone Neoplasms; Cattle; Culture Media; Cytarabine; Dialysis; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Fetal Blood; Humans; Hypoxanthine; Methotrexate; Neoplasm Proteins; Nucleotides; Osteosarcoma; Tetrahydrofolate Dehydrogenase; Thymidine; Tumor Cells, Cultured; Vidarabine | 2002 |
Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.
Topics: Antimetabolites, Antineoplastic; Blood Cell Count; Chemical and Drug Induced Liver Injury; Cytarabine; Dipyridamole; Drug Interactions; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Liver Function Tests; Male; Middle Aged; Multiple Organ Failure; Platelet Aggregation Inhibitors | 2004 |
Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
Topics: Cell Line, Tumor; Cell Survival; Cytarabine; Cytidine Deaminase; Cytoprotection; Deoxycytidine Kinase; Dipyridamole; Drug Resistance, Neoplasm; Gene Expression; Humans; Leukemia; RNA, Messenger; Thioinosine | 2007 |
Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126.
Topics: Antineoplastic Agents; Cell Line; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Dipyridamole; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Nucleoside Transport Proteins; Nucleotidases | 2012 |
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.
Topics: Animals; Antimetabolites, Antineoplastic; Child; CHO Cells; Cohort Studies; Cricetulus; Cytarabine; Deoxycytidine; Dipyridamole; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Profiling; HEK293 Cells; HeLa Cells; Humans; Leukemia, Myeloid, Acute; Organic Cation Transport Proteins; Symporters | 2017 |